PLEKHF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.71389594025595E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.14390000003095E-06 |
Normal-vs-Stage2 |
3.644900E-03 |
Normal-vs-Stage3 |
4.73460159966521E-11 |
Normal-vs-Stage4 |
1.62458935193399E-12 |
Stage1-vs-Stage2 |
5.051400E-01 |
Stage1-vs-Stage3 |
2.973900E-04 |
Stage1-vs-Stage4 |
1.02699999615652E-08 |
Stage2-vs-Stage3 |
1.175820E-01 |
Stage2-vs-Stage4 |
2.945600E-02 |
Stage3-vs-Stage4 |
3.024200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.85940041141919E-10 |
Normal-vs-AfricanAmerican |
3.30410143689619E-11 |
Normal-vs-Asian |
1.502380E-01 |
Caucasian-vs-AfricanAmerican |
2.539600E-02 |
Caucasian-vs-Asian |
5.028000E-01 |
AfricanAmerican-vs-Asian |
8.907500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.13310496938379E-11 |
Normal-vs-Female |
5.17910000441546E-08 |
Male-vs-Female |
3.568600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.93399999962141E-07 |
Normal-vs-Age(41-60Yrs) |
5.07430000240561E-08 |
Normal-vs-Age(61-80Yrs) |
5.2996051991272E-11 |
Normal-vs-Age(81-100Yrs) |
1.147510E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.155180E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.046800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.418800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.686400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.213400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.396000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.900500E-02 |
Normal-vs-Grade 2 |
7.594100E-04 |
Normal-vs-Grade 3 |
1.75703895877177E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
9.566400E-01 |
Grade 1-vs-Grade 3 |
5.457600E-02 |
Grade 1-vs-Grade 4 |
1.34650000005454E-06 |
Grade 2-vs-Grade 3 |
6.17800000000113E-05 |
Grade 2-vs-Grade 4 |
9.43689570931383E-15 |
Grade 3-vs-Grade 4 |
1.14210000012882E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.936400E-03 |
Normal-vs-ccB subtype |
1.81155090928087E-12 |
ccA subtype-vs-ccB subtype |
6.46819999783332E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.00889995936183E-09 |
Normal-vs-N1 |
5.48149969858969E-10 |
N0-vs-N1 |
6.433300E-04 |
|
|